WithdrawnNo phase
TcMS to Treat Ventricular Tachycardia
Reason given: Alternate study pursued
Key facts
- Where
- Philadelphia, United StatesSee the site
Where in United States
- Hospital of the University of PennsylvaniaPhiladelphia, United StatesNo longer taking part
Trial details
- Who runs it
- University of Pennsylvania
- Trial code
- NCT05016921
- Record updated
- 4 April 2024
- Original description
Open label study of transcutaneous magnetic stimulation targeting the stellate ganglion in patients with ventricular tachycardiaRead full original descriptionShow less
Transcutaneous Magnetic Stimulation of the Stellate Ganglion to Treat Ventricular Tachycardia
Open label study of transcutaneous magnetic stimulation targeting the stellate ganglion in patients with ventricular tachycardia
Inclusion: Age >18years; Documented ventricular tachycardia within the preceding 72 hours.
Exclusion: Implanted medication pumps; Cochlear implant; Ocular implant; History of malignancy in the region of stimulation (neck); Pregnancy; Implanted ventricular assist device; Metal implanted in heard or neck (except the mouth); Implanted brain stimulator.